 in people with chronic kidney disease and found that there were benefits. It's being studied for liver disease, all sorts of currently off-label conditions. At Johns Hopkins, I'm Elizabeth Tracy. You're listening to WIQO, where you always get the best coverage of news stories from Lynchburg to Bedford to Danville and everywhere in between.